Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

UCB

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.

UCB

Roche pays $120m upfront for UCB’s anti-tau Alzheimer’s drug

Roche pays $120m upfront for UCB’s anti-tau Alzheimer’s drug

UCB is already developing UCB0107 in PSP, with a confirmatory phase 3 study due to begin in the second quarter of 2021. ... If this proves successful, Roche will have the option to take over subsequent development or return the rights back to UCB.

Mapping the patient journey and minding the gap

Mapping the patient journey and minding the gap UCB has reconfigured its teams around Patient Value Units. Novo Nordisk has established Disease Experience Expert Panels (DEEP), an approach based on ‘an evolving world view where people with serious chronic

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe

UCB/Amgen’s Evenity finally cleared for osteoporosis in Europe UCB and Amgen have finally claimed European approval for their osteoporosis drug Evenity, which becomes the first new drug for the disease in the EU since 2010. ... The first launches of romosozumab in the European Economic Area (EEA) are planned for the

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial

UCB’s bimekizumab beats AbbVie’s Humira in phase 3 trial UCB’s drug also met all of its secondary endpoints with statistical significance – this includes superior total skin clearance at weeks 16 and 24 compared to Humira. ... UCB is committed to addressing the critical unmet needs of adult patients with

You Go Beyond

No Compromise For Her’ Creative Educational Campaign - by UCB Pharma S.A.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics